Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
EV/Core EBITDA

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 56.5542.30-6.02-4.82-2,930.49

What is the latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA ?

The latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA is 56.55 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202656.55
Mar202542.30
Mar2024-6.02
Mar2023-4.82
Mar2022-2,930.49

How is EV/Core EBITDA of ONESOURCE SPECIALTY PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 56.55
33.69
Mar2025 42.3
Positive
Mar2024 -6.02
Negative
Mar2023 -4.82
Negative
Mar2022 -2930.49 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare EV/Core EBITDA ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹16,418.7 Cr -2.3% -10.5% -23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,427.0 Cr 0.2% -4.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹239,982.0 Cr -3.1% -1.6% 47.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,196.0 Cr -1.2% -5% 29.4% Stock Analytics
CIPLA ₹107,746.0 Cr 2.3% -2% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,894.0 Cr 2.2% 6.2% -2.5% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

-2.3%

-10.5%

-23.5%

SENSEX

3.8%

-0.6%

-9.1%


You may also like the below Video Courses